Precigen PGEN
NASDAQ PGEN
$6.80 -0.07 (-1.02%)
As of: Sep 9, 2026 · 3:59 PM EDT

Precigen (PGEN) Short term Debt (2013 - 2023)

Precigen's (PGEN) quarterly Short term Debt came in at $13.8 million in Q1 2023, up 8326.22% year-over-year from $164000.0 in Q1 2022, and down 68.03% quarter-over-quarter from $43.2 million in Q4 2022.

Analysis

Precigen (PGEN) Short term Debt (2013 - 2023) Analysis & Trends

Precigen (PGEN) has reported Short term Debt for 11 consecutive years, with $13.8 million the latest figure, recorded in Q1 2023.

  • On a quarterly basis, Short term Debt rose 8326.22% year-over-year to $13.8 million in Q1 2023; TTM through Mar 2023 was $13.8 million, a 8326.22% increase from a year earlier, with the FY2022 full-year figure at $43.2 million, up 83013.46% from the prior year.
  • Short term Debt was $13.8 million for Q1 2023 at Precigen, down from $43.2 million in the prior quarter.
  • Over five years, Short term Debt peaked at $82.1 million in Q3 2022 and troughed at $52000.0 in Q4 2021.
  • A 5-year average of $15.9 million and a median of $468000.0 in 2019 frame the typical range for Short term Debt.
  • Across the five-year window, Short term Debt slumped 98.89% in 2021 and surged 83013.46% in 2022, its largest moves.
  • Over 5 years, Short term Debt stood at $31.7 million in 2019, then plunged by 98.86% to $360000.0 in 2020, then sank by 85.56% to $52000.0 in 2021, then surged by 83013.46% to $43.2 million in 2022, then tumbled by 68.03% to $13.8 million in 2023.
  • The last three Short term Debt figures came in at $13.8 million (Q1 2023), $43.2 million (Q4 2022), and $82.1 million (Q3 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Taysha Gene Therapies 1.97 Bn 1.97 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 13.82 Mn
Dec 31, 2022 43.22 Mn
Sep 30, 2022 82.07 Mn
Jun 30, 2022 277,000.00
Mar 31, 2022 164,000.00
Dec 31, 2021 52,000.00
Sep 30, 2021 355,000.00
Jun 30, 2021 356,000.00
Mar 31, 2021 359,000.00
Dec 31, 2020 360,000.00
Sep 30, 2020 421,000.00
Jun 30, 2020 32.11 Mn
Mar 31, 2020 31.89 Mn
Dec 31, 2019 31.67 Mn
Sep 30, 2019 31.43 Mn
Jun 30, 2019 468,000.00
Mar 31, 2019 564,000.00
Dec 31, 2018 479,000.00
Sep 30, 2018 546,000.00
Jun 30, 2018 574,000.00